Doctors say this common diet could be worsening your IBD symptoms – find out what to avoid nowDoctors warn that diet can play a big role in inflammatory bowel disease (IBD). Eating anti-inflammatory foods like fruits, vegetables, and...
18 Sep, 2025, 01.12 AM IST
Mankind gets CDSCO nod for Phase 1 clinical trials for molecule to treat autoimmune disordersMankind Pharma has received CDSCO approval to begin Phase 1 clinical trials for MKP11093, a molecule targeting multiple autoimmune disorder...
08 Sep, 2025, 12.43 PM IST
Biocon Biologics secures multiple market access agreements in US for YesintekBiocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 million lives. Mult...
05 May, 2025, 10.38 AM IST
Biocon Biologics inks licence pact with Janssen for biosimilar productThe agreement licenses the company to launch in the US in February 2025, once approved by the US Food and Drug Administration(USFDA), Bioco...
29 Feb, 2024, 09.44 PM IST
India sees significant increase in inflammatory bowel disease, says Lancet studyA recent study by the IBD Center of the Asian Institute of Gastroenterology (AIG) in Hyderabad, India, shows that prevalence of inflammator...
07 Aug, 2023, 07.49 AM IST
Urbanisation intensifies the prevalence of inflammatory bowel disease in India, reveals Lancet StudyThe last two decades have seen an increasing incidence and prevalence of IBD in the Asia-Pacific region and that India appeared to be in an...
04 Aug, 2023, 06.23 PM IST
Aurobindo Pharma subsidiary enters pact with BioFactura for biosimilar ustekinumabCuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma said it has entered into an exclusive license agreement with the US-based ...
10 Jul, 2023, 07.13 PM IST
Patients with inflammatory bowel disease may experience a stroke; know why this condition weakens your heartAccording to the Mayo Clinic IBD refers to chronic inflammation of the tissues in our digestive tract.
17 Jun, 2023, 07.57 PM IST
Biocon starts clinical study to evaluate efficacy of ItolizumabThis is a phase two randomised, double-blind, parallel-group, placebo and active-controlled (adalimumab), two treatment period study to eva...
15 Dec, 2022, 11.21 AM IST
Alembic Pharma receives final approval from USFDA for generic Mesalamine extended-release capsulesThe approved drug is therapeutically equivalent to Salix Pharmaceuticals Inc's reference listed drug (RLD), Apriso extended-release capsule...
02 Nov, 2022, 10.57 AM IST
Former Japan PM Shinzo Abe shot in chest, showing no vital signs. Attacker arrestedThe reporter claimed to have heard 'consecutive bangs', after which Abe was seen in blood. The suspect is reportedly a middle-aged man, acc...
08 Jul, 2022, 11.42 AM IST
Zydus Cadila gets tentative USFDA nod for generic drugThe company has received tentative approval from the US Food and Drug Administration (USFDA) for the product which is the generic version o...
19 Oct, 2020, 12.55 PM IST
Zydus Cadila gets USFDA nod for its ulcerative colitis drugThe company has received final approval from the USFDA for Mesalamine delayed-release tablets in the strength of 800 mg, Zydus Cadila said ...
25 Jul, 2017, 02.12 PM IST
US court rules in favour of Zydus Cadila in patent caseThe US Court of Appeals for the Federal Circuit has affirmed judgement in favour of Zydus Pharmaceuticals (USA) Inc.
10 May, 2017, 02.19 PM IST
Lupin gets FDA nod to market ulcerative colitis tablets in USThe company has received tentative approval to market its Balasalazide Disodium tablets 1.1 gm from the United States Food and Drug Adminis...
29 Dec, 2016, 03.43 PM IST
People may inherit 'gut' bacteria that cause Crohn's diseaseScientists have shown for the first time that people may inherit some of the intestinal bacteria that cause Crohn's disease and ulcerative ...
17 Dec, 2014, 04.34 PM IST
Glenmark enters phase II clinical trial for new drug moleculeGlenmark Pharmaceuticals said it has entered the phase II clinical trials for its new drug molecule aimed at treating ulcerative colitis.
13 Sep, 2012, 03.26 PM IST